AI assistant
Sending…
Active Biotech — Major Shareholding Notification 2023
Nov 10, 2023
3133_iss_2023-11-10_92eff074-7507-471b-a813-84bab672130e.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer Active Biotech AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Share loan | |
| Date | 09/11/2023 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 10,282,663 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 10,282,663 |
| Percentage | |
| Directly held shares | 3.87813 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 3.87813 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 3.87813 % | 10,282,663 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 1.75606 % | 4,656,105 |
| Total | 5.63419 % | 14,938,768 |
Group total holdings
Voting rights 14,938,768 Percentage of voting rights 5.63419
Notes (other relevant informations according to law)
Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har underskridits på grund av utlåning av aktier.
Published
10/11/2023 13:12
Contact
Name Joakim Lomell
Email [email protected]
*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Active Biotech
Quarterly Report
2026
May 7
Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 17
Annual Report (ESEF)
2026
Apr 1
Audit Report / Information
2026
Feb 12
Audit Report / Information
2026
Feb 12
Share Issue/Capital Change
2026
Jan 30
Share Issue/Capital Change
2026
Jan 30
Regulatory Filings
2026
Jan 21